COMMODORE CAPITAL LP
Latest 13F filing data - Q4 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | RLAY | 17.00M | $143.82M |
 | PALI | 11.45M | $26.90M |
 | CTMX | 7.69M | $32.77M |
 | AMLX | 5.65M | $68.25M |
 | IKT | 5.40M | $11.06M |
 | ELVN | 4.69M | $72.27M |
 | SABS | 4.40M | $16.46M |
 | ALKS | 3.55M | $99.33M |
 | PEPG | 3.40M | $22.13M |
 | TYRA | 3.38M | $88.73M |
 | CLDX | 2.56M | $69.67M |
 | SYRE | 2.39M | $78.24M |
 | NRIX | 2.27M | $43.16M |
 | COGT | 2.20M | $78.03M |
 | MNMD | 2.00M | $26.78M |
 | PHVS | 1.89M | $52.43M |
 | ANRO | 1.82M | $32.45M |
 | XENE | 1.80M | $80.68M |
 | ORKA | 1.75M | $53.14M |
 | LBRX | 1.50M | $33.39M |
Relay Therapeutics, Inc.
RLAY
Shares Held
17.00M
Value
$143.82M
Palisade Bio, Inc.
PALI
Shares Held
11.45M
Value
$26.90M
CytomX Therapeutics, Inc.
CTMX
Shares Held
7.69M
Value
$32.77M
Amylyx Pharmaceuticals, Inc.
AMLX
Shares Held
5.65M
Value
$68.25M
Inhibikase Therapeutics, Inc.
IKT
Shares Held
5.40M
Value
$11.06M
Enliven Therapeutics, Inc.
ELVN
Shares Held
4.69M
Value
$72.27M
SAB Biotherapeutics, Inc.
SABS
Shares Held
4.40M
Value
$16.46M
Alkermes plc
ALKS
Shares Held
3.55M
Value
$99.33M
PepGen Inc.
PEPG
Shares Held
3.40M
Value
$22.13M
Tyra Biosciences, Inc.
TYRA
Shares Held
3.38M
Value
$88.73M
Celldex Therapeutics, Inc.
CLDX
Shares Held
2.56M
Value
$69.67M
Spyre Therapeutics, Inc.
SYRE
Shares Held
2.39M
Value
$78.24M
Nurix Therapeutics, Inc.
NRIX
Shares Held
2.27M
Value
$43.16M
Cogent Biosciences, Inc.
COGT
Shares Held
2.20M
Value
$78.03M
Mind Medicine (MindMed) Inc.
MNMD
Shares Held
2.00M
Value
$26.78M
Pharvaris N.V.
PHVS
Shares Held
1.89M
Value
$52.43M
Alto Neuroscience, Inc.
ANRO
Shares Held
1.82M
Value
$32.45M
Xenon Pharmaceuticals Inc.
XENE
Shares Held
1.80M
Value
$80.68M
Oruka Therapeutics, Inc.
ORKA
Shares Held
1.75M
Value
$53.14M
LB Pharmaceuticals Inc Common Stock
LBRX
Shares Held
1.50M
Value
$33.39M